The Netherlands, 01 October 2014 – Synaffix BV, today announced the appointment of Mr. Anthony DeBoer as its Director of Business Development.
Previously, Mr. DeBoer served as the Associate Director of Business Development at Allozyne Inc., a Seattle-based biotechnology and protein therapeutics company. While at Allozyne, he was focused on key partnering efforts around its ADC platform technology as well as preclinical to Phase III-ready pipeline programs, leading up to the acquisition by MedImmune.
